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places in the world (2,7), two major
HMPV groups exist. The severity of
the episodes observed varied from
mild upper respiratory symptoms to
severe infections requiring hospital-
ization for 2–6 days. Overall, as
reported by other authors (2,8), the
clinical picture provoked by HMPV
was indistinguishable from that of
other respiratory viruses. The fact that
HMPV was not detected in any of the
samples from patients also positive
for other respiratory viruses suggests
that coinfection is infrequent. The
data reported in our study, obtained
during two consecutive winter sea-
sons in a pediatric population of
southern Europe, allow us to estimate
that the incidence of moderate or
severe respiratory infections caused
by HMPV is low and that the impact
of the other respiratory viruses is con-
siderably greater. Despite these
results, we think that this new respira-
tory pathogen warrants surveillance.
HMPV appears to be capable of pro-
voking severe infections, and its role
in human respiratory infections is still
poorly understood. 
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Puumala Virus
Infection with
Acute
Disseminated
Encephalomyelitis
and Multiorgan
Failure
To the Editor: Hantaviruses,
which belong to the genus
Hantavirus, family Bunyaviridae, are
human pathogens that are prevalent
worldwide (1). More than 16 different
genotypes or serotypes have been
identified (e.g., Puumala, Hantaan,
Dobrava-Belgrade, Seoul, Sin
Nombre). In western and central
Europe, the predominant serotype is
Puumala, which causes nephropathia
epidemica. Puumala virus (PUUV) is
spread by rodents and is transmitted to
humans by inhalation or ingestion of
food contaminated with rodent excre-
ta (2). Nephropathia epidemica is
endemic in western Russia, Finland,
Sweden, France, Belgium, Germany,
and former Yugoslavia. Reports of
serologically verified nephropathia
epidemica cases have also been pub-
lished from Denmark, Norway, the
Netherlands, and Austria (3). In
Austria, the risk for infection seems to
be restricted to special areas in Styria
and Carinthia where Clethrionomys
glareolus, the reservoir of PUUV in
Austria, is endemic. The seropreva-
lence in Finland is 5% and 1.8% in
Austria (4). The most common symp-
toms of nephropathia epidemica are
fever, nausea, vomiting, headache,
stomachache, back pain, tenderness in
the kidney area, diarrhea or constipa-
tion, and red throat (5). PUUV infec-
tion may also lead to neurologic
symptoms including meningoen-
cephalitis, polyradiculitis, seizures,
cerebral hemorrhage, urinary bladder
paralysis, and hypopituitarism (6,7).
Our patient, a 43-year-old previ-
ously healthy man, had a temperature
of 39°C and acute abdominal pain.
Two days after the symptoms began,
he was admitted to a regional hospital
where acute renal failure and dissem-
inated intravascular coagulation
developed in the next 2 days. The
patient was transferred to the
Department of Medicine, Karl-
Franzens University Graz, for inten-
sive care. The patient worked in a fac-
tory, and he hunted in his spare time.
A few days before his illness began,
he had cleaned up his hut in the forest. 
On admission to the intensive care
unit, physical examination showed
abdominal guarding and a body tem-
perature of 39.2°C. Laboratory tests
showed thrombocytes 36 G/L
(140–440 G/L), creatinine 3.6 mg/dL
(0.6–1.3 mg/dL), urea 132 mg/dL
(10–45 mg/dL), D-dimere 1,558 µg/L
(<200 µg/L), ATIII 67% (>75%), c-
reactive protein (CRP) 237 mg/L (<9
mg/L), lactate dehydrogenase (LDH)
322 U/L, and slightly elevated liver
enzymes. Computer tomography (CT)
of the thorax showed bilateral opaci-604 Emerging Infectious Diseases • Vol. 9, No. 5, May 2003
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ties in the lungs and pleural effusion.
In the CT of the abdomen, a thickened
wall of the colon ascendens, an
enlarged caecum, slightly enlarged
kidneys, approximately 500 mL of
ascites, and enhancement of the peri-
toneum were found. Gastroscopy and
colonoscopy results were normal. In
the ascites, protein of 3.1 g/dL and
1,000 cells/L with 73% neutrophils
were detected. A few hours after
admission to the intensive care unit,
the patient’s level of consciousness
started to deteriorate, and respiratory
failure and circulatory insufficiency
with a blood pressure of 78/50 devel-
oped. He was intubated and ventilat-
ed, received catecholamines, and was
empirically treated with meropenem
and clarithromycin adjusted to renal
function. Liquor examination showed
elevated lactate (2.7 mmol/L; normal
range 2.1 mmol/L) and elevated pro-
tein (67 mg/dL; normal range 45
mg/dL). Detailed cerebral spinal fluid
testing did not show additional infor-
mation. Despite antibiotic therapy,
abdominal tenderness, organ func-
tions, and laboratory test results wors-
ened. Four days later antibiotic thera-
py was changed to ciprofloxacin and
metronidazole adjusted to renal func-
tion and the patient was hemodialized.
Because of increasing ascites, ileus,
and raising CRP (from 216 to 391
mg/L) in the next 3 days, explorative
laparotomy was performed, but no
focus of infection could be found.
One day after surgery, meningism and
hyperreflexia developed. A brain CT
showed wide areas of hypodensity
bilateral in the white matter partially
involving the cortex. Magnetic reso-
nance imaging (MRI) showed bilater-
al areas of increased signal intensity
located in the parietooccipital region
extending to the frontal, temporal, and
pons regions and associated with cere-
bral edema. The lesions predominately
affected the white matter but, particu-
larly in the occipital region, also
involved the cortex. Because of the
patient’s history and his recent activi-
ties in his forest hut, serum samples
were investigated for antibodies
against PUUV, Leptospira sp.,
Ehrlichia sp., Borrelia sp., Francisella
tularensis, Bartonella henselae, and
Coxiella burnetii. PUUV antibodies
were found to be positive (highest
titers: immunoglobulin (Ig) M 1:64,
IgG 1:8000) in an immunofluores-
cence test (Progen, Heidelberg,
Germany) and an immunoassay
(Mikrogen, Martiensried, Germany).
The patient further received cate-
cholamines, hemodialysis, and
mechanical ventilation. In the week
after surgery, he improved clinically,
and catecholamines, hemodialysis,
and mechanical ventilation were
stopped 15 days after initiation. One
week later, a second brain MRI
showed resolving abnormalities. Four
weeks after admission to the intensive
care unit, the patient left the hospital
in good condition. Two months later,
MRI of the brain was normal, and the
patient was well at an 18-month fol-
low-up. 
A few reports of hantavirus infec-
tion with cerebral involvement have
been published. Recently, a patient
with acute disseminated encephalo-
myelitis following nephropathia epi-
demica was reported (2). Whereas this
patient had acute renal failure and
acute disseminated encephalo-
myelitis, our patient suffered from
multiorgan failure with respiratory,
circulatory, and renal insufficiency,
paralytic ileus, disseminated intravas-
cular coagulation, and acute dissemi-
nated encephalo-myelitis. In addition,
in our patient, the disseminated
encephalomyelitis involved pari-
etooccipital, temporal, and frontal
regions of the brain and also reached
the brain stem. Other causes of acute
disseminated encephalomyelitis such
as multiple sclerosis, encephalitis
caused by other infectious agents, ure-
mic encephalitis, and hypertensive
encephalitis could be ruled out. 
In our patient, abdominal pain,
ileus, thickened wall of the colon, and
enlargement of the caecum mimicked
acute abdomen, which has also been
reported in two other cases of han-
tavirus infection (8). Usually han-
taviruses are transmitted by inhalation
of virus-containing particles originat-
ing from rodents urine, droppings,
and saliva. Therefore, transmission
can occur at any place that infected
rodents have infested (9). In our
patient, the probable source of infec-
tion was his housecleaning activities
in his hut a few days before his ill-
ness. Since this hut served as a storage
facility and was rarely entered, it was
occupied by rodents.
In summary, PUUV infection
should be considered in the differen-
tial diagnosis of multiorgan failure
and acute disseminated encephalo-
myelitis, especially in patients from
PUUV-endemic areas and typical his-
tory.
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Pregnancy and
Asymptomatic
Carriage of
Pneumocystis
jiroveci
To the Editor: Severe immuno-
suppression is the leading determinant
host factor for Pneumocystis pneumo-
nia (PCP) (1). However, PCP is not
restricted to those who are severely
immunocompromised. Molecular
techniques based on the amplification
of specific regions of P. jiroveci
(human-derived Pneumocystis) DNA
by using polymerase chain reaction
(PCR) in noninvasive human samples
suggest that the infection is common
in other segments of the population
that are immunocompetent or display
a lesser degree of immune compro-
mise (2,3). A mild or asymptomatic
form of P. jiroveci infection, or a car-
rier state, likely develops in these per-
sons, who may play a role in the cir-
culation of P. jiroveci in the communi-
ty while serving as silent reservoirs
for transmission to susceptible per-
sons. This description fits infants who
acquire the primary Pneumocystis
infection very early in life, patients
with chronic respiratory disorders,
elderly adults, and other groups (2,3).
Extensive searches have been unsuc-
cessful in detecting carriage of P.
jiroveci DNA in noninvasive samples
(i.e., nasal and throat swabs, saliva)
from immunocompetent healthy
adults (4). 
Evidence suggests that latency of
P. jiroveci is time-limited and that PCP
is more likely an actively acquired
infection (1). Characterization of
potentially infectious reservoirs might
lead to new intervention strategies to
prevent transmission. Furthermore,
the detection of P. jiroveci strains with
mutations at the dihydropteroate syn-
thase locus, which in other pathogens
confer resistance to trimethoprim-sul-
famethoxazole, suggests that resist-
ance to this primary therapy of PCP
may be emerging (1). New strategies
for P. jiroveci prophylaxis may soon
be needed.
Evidence suggests that normal
pregnancy may be accompanied by
changes in the immune response that
may in part account for the successful
growth and delivery of the “fetus
hemi-allograft.” A subtle shift from
the response of Th1 (cellular immuni-
ty) CD4+ lymphocytes to a propor-
tional increase in the Th2 (humoral
immunity) CD4+ response can be
detected (5). These responses have
not been clearly explained but would
most likely occur because of shifts in
the production of cytokines, impairing
defense against certain infections.
Pregnancy’s important hormonal
changes (e.g., increases in the secre-
tion of human chorionic gona-
dotropin, progesterone, estrogen, cor-
ticosteroids,  α-fetoprotein, prolactin,
and α-globulin) may also contribute
to decreased resistance. While overt
immune deficiency is difficult to
detect, an increase in some viral infec-
tions has been documented, which
may indicate a gentle form of
depressed immune response (6). In
addition, this physiologic compensa-
tion generates an increase in illness
and death from other infections that
require a protective Th1 response as,
for example, tuberculosis, malaria,
American trypanosomiasis, leishma-
niasis, toxoplasmosis, lysteriosis, and
pneumocystosis. Reports indicate that
illness in HIV-infected women with
PCP is greater when the women are
pregnant (7). However, no data show
that pregnant women may be asymp-
tomatic carriers of P. jiroveci. 
A prospective, pilot study of 33
third-trimester, pregnant, asympto-
matic healthy women and 28 healthy
women within 15 days of a menstrual
period (controls) was conducted.
Participants were followed at an outpa-
tient clinic in Santiago during January
through March 2002. Ages were 14–39
years (median 26 years) for pregnant
women and 17–45 years (median 28
years) for controls. Previous pregnan-
cies ranged from 0 (n=10) to 4 (medi-
an 1) for pregnant women and from 0
(n=9) to 3 (median 1) for controls. P.
jiroveci was detected in deep nasal
swab samples in a nested-PCR proce-
dure by using oligonucleotide primers
pAZ102E and pAZ102H. (These
primers were designed for the gene
encoding the mitochondrial large sub-
unit rRNAof rat-derived Pneumocystis
[P. carinii] that amplifies all forms of
Pneumocystis and internal primers
pAZ102X and pAZ102Y, specific for
P. jiroveci.) DNA extraction was per-
formed with a commercial kit
(QIAamp DNA mini kit; Qiagen Inc.,
Valencia, CA). Positive, negative, and
internal control primers, directed to the
human globin gene to detect sample
inhibition and verify successful extrac-
tion, were used during the DNAampli-
fication procedure. Samples were
processed under a laminar flow hood
to prevent contamination, and PCR
assays were repeated twice. The Ethics
Committee of the University of Chile
School of Medicine approved the
study.